AOD-9604 (AOD)

Fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis without the growth-promoting effects of HGH.

Key Data

Research Status

Clinical trials

Half-Life

Unknown (short)

Administration

Subcutaneous injection

Typical Dosage

250-500 mcg

Mechanism of Action

Mimics the fat-burning portion of HGH without affecting IGF-1 or insulin. Stimulates lipolysis.

Reported Benefits

• Fat metabolism
• No IGF-1 increase
• Cartilage repair potential
• Weight management

All information is presented for Research Use Only (RUO). Not medical advice.